What is Figure 1?
Headquartered in Toronto, Figure 1 operates a specialized mobile-first network designed to facilitate the exchange of medical knowledge among healthcare practitioners worldwide. By providing a secure environment for viewing and discussing complex clinical cases, the platform serves as a digital hub for medical education and peer-to-peer consultation. Its market position is defined by its ability to aggregate high-value clinical data while maintaining strict adherence to privacy standards, effectively transforming how medical professionals collaborate in a digital-first landscape.
How much funding has Figure 1 raised?
Figure 1 has raised a total of $19.5M across 4 funding rounds:
Angel/Seed
$2M
Private Equity
$2.5M
Series A
$5M
Series B
$10M
Angel/Seed (2013): $2M with participation from Rho Canada Ventures, Investment Accelerator Fund, Ryerson Futures Inc., and VersionOne
Private Equity (2015): $2.5M, investors not publicly disclosed
Series A (2015): $5M supported by VersionOne, Union Square Ventures, Rho Canada Ventures, and Allen & Company
Series B (2017): $10M featuring Hedgewood, John Hancock, VersionOne, Western Technology Investment, Samsung NEXT, Union Square Ventures, Rho Canada Ventures, and Kensington Capital Partners
Key Investors in Figure 1
VersionOne
Version One Ventures is an early-stage venture fund that invests in mission-driven founders in emerging markets, focusing on companies that are transforming various industries.
Union Square Ventures
Union Square Ventures is a New York City-based venture capital firm that invests in transformative markets influenced by technological and societal changes.
Rho Canada Ventures
Rho is a venture capital firm that has been investing in innovation since 1981, partnering with entrepreneurs to create market-defining businesses.
What's next for Figure 1?
With the recent influx of capital, Figure 1 is well-positioned to accelerate its international expansion and deepen its integration within clinical workflows. The strategic focus will likely shift toward enhancing the platform's analytical capabilities and expanding its user base across emerging markets. By leveraging its established network, the company aims to solidify its role as the primary digital interface for clinical decision support, ensuring that its technological infrastructure remains at the forefront of the rapidly evolving digital health sector.
See full Figure 1 company page